|
Up a level |
Jones, A M E; Aebersold, R; Ahrens, C H; Apweiler, R; Baerenfaller, K; Baker, M; Bendixen, E; Briggs, S; Brownridge, P; Brunner, E; Daube, M; Deutsch, E W; Grossniklaus, U; Heazlewood, J L; Hengartner, M O; Hermjakob, H; Jovanovic, M; Lawless, C; Lochnit, G; Martens, L; Ravnsborg, C; Schrimpf, S P; Shim, Y H; Subasic, D; Tholey, A; van Wijk, K; von Mering, C; Weiss, M; Zheng, X (2012). The HUPO initiative on Model Organism Proteomes, iMOP. Proteomics, 12(3):340-345.
Mackenzie, I R A; Ansorge, O; Strong, M; Bilbao, J; Zinman, L; Ang, L C; Baker, M; Stewart, H; Eisen, A; Rademakers, R; Neumann, M (2011). Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathologica, 122(1):87-98.
Neumann, M; Rademakers, R; Roeber, S; Baker, M; Kretzschmar, H A; Mackenzie, I R A (2009). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain: A Journal of Neurology, 132(Pt 11):2922-2931.
Neumann, M; Roeber, S; Kretzschmar, H A; Rademakers, R; Baker, M; Mackenzie, I R A (2009). Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathologica, 118(5):605-616.